Budapest, Hungary

Vajk Horváth


 

Average Co-Inventor Count = 15.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inventor Vajk Horváth: Pioneering Innovations in Pharmaceuticals

Introduction

Vajk Horváth is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative research and development of compounds that selectively inhibit myosin 2 isoforms.

Latest Patents

Horváth holds a patent titled "Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms." This invention encompasses compounds of specific formulas, including their pharmaceutically acceptable salts, solvates, tautomers, stereoisomers, enantiomers, diastereomers, and racemic mixtures. The patent highlights the potential pharmaceutical uses of these compounds which could contribute substantially to therapeutic advances.

Career Highlights

Throughout his career, Vajk Horváth has worked with renowned institutions and companies, including Eötvös Loránd University and Printnet Kereskedelmi és Szolgáltató Kft. His tenure in these organizations has bolstered his expertise and bolstered his research capabilities in pharmaceutical sciences.

Collaborations

In his professional journey, Vajk has collaborated with esteemed colleagues such as András Málnási-Csizmadia and Maté Gyimesi. These collaborations have certainly added depth to his research and have proven beneficial in advancing their collective work in the field.

Conclusion

Vajk Horváth's contributions to the pharmaceutical industry through his innovative patents and collaborative efforts have established him as a prominent figure in his field. His dedication to research and development serves as an inspiration for future inventors in the realm of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…